---
document_datetime: 2023-09-21 17:13:41
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ammonaps-epar-all-authorised-presentations_en.pdf
document_name: ammonaps-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9633888
conversion_datetime: 2025-12-29 19:59:36.934516
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical form   | Route of administration   | Packaging   | Package size            |
|-----------------|-----------------|------------|-----------------------|---------------------------|-------------|-------------------------|
| EU/1/99/120/001 | Ammonaps        | 500 mg     | Tablets               | Oral use                  | HDPE bottle | 250 tablets             |
| EU/1/99/120/002 | Ammonaps        | 500 mg     | Tablets               | Oral use                  | HDPE bottle | 500 tablets             |
| EU/1/99/120/003 | Ammonaps        | 940 mg/g   | Granules              | Oral use                  | HDPE bottle | 266 g + 3 dosing spoons |
| EU/1/99/120/004 | Ammonaps        | 940 mg/g   | Granules              | Oral use                  | HDPE bottle | 532 g + 3 dosing spoons |